TY  - GEN
AU  - Zhao,Min
AU  - Mantel,Irmela
AU  - Gelize,Emmanuelle
AU  - Li,Xinxin
AU  - Xie,Xiaoyue
AU  - Arboleda,Alejandro
AU  - Seminel,Marie
AU  - Levy-Boukris,Rinath
AU  - Dernigoghossian,Marilyn
AU  - Prunotto,Andrea
AU  - Andrieu-Soler,Charlotte
AU  - Rivolta,Carlo
AU  - Canonica,Jérémie
AU  - Naud,Marie-Christine
AU  - Lechner,Sebastian
AU  - Farman,Nicolette
AU  - Bravo-Osuna,Irene
AU  - Herrero-Vanrell,Rocio
AU  - Jaisser,Frederic
AU  - Behar-Cohen,Francine
TI  - Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
SN  - 2041-1723
PY  - 2019///0205
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Animals
KW  - Choroid
KW  - drug effects
KW  - Choroidal Neovascularization
KW  - drug therapy
KW  - Drug Compounding
KW  - methods
KW  - Female
KW  - Gene Expression
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Degeneration
KW  - Male
KW  - Mice
KW  - Mice, Transgenic
KW  - Microspheres
KW  - Mineralocorticoid Receptor Antagonists
KW  - Pilot Projects
KW  - Prospective Studies
KW  - Ranibizumab
KW  - Rats, Long-Evans
KW  - Receptors, Mineralocorticoid
KW  - genetics
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Recombinant Fusion Proteins
KW  - Spironolactone
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41467-018-08125-6
ER  -